NCT00005040View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2000

Primary Completion Date

July 31, 2001

Study Completion Date

July 31, 2001

Conditions
Lymphoma
Interventions
DRUG

arsenic trioxide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005040 - Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter